YOU ARE HERE: LAT HomeCollectionsGlaxosmithkline Company

Glaxosmithkline Company

October 18, 2011 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
A malaria vaccine under development has passed a critical milestone with researchers reporting Tuesday that the shots protect about half of all children from the disease. The Phase 3 clinical trial was conducted among 6,000 sub-Saharan African children five to 17 months old who were given three doses. The vaccine is designed to prevent the malaria parasite from infecting, maturing and multiplying in the liver and reentering the bloodstream. A malaria vaccine has been a goal for more than 20 years.
June 19, 2006 | Emily Sohn, Special to The Times
WALTER Skotchdopole worked for 20 years as a police officer and 20 years in the film industry before succumbing to the relentless decline of Alzheimer's disease. In his prime, he joked with everyone he met. By his early 70s, he had become a shell of his former self. "He's there, but he's not," says his son James Skotchdopole. "There's no real interaction, no real stake in life." Walter Skotchdopole had tried several drugs, with no noticeable improvement.
May 22, 2007 | Karen Kaplan and Ricardo Alonso-Zaldivar, Times Staff Writers
A widely prescribed drug to treat Type 2 diabetes substantially increases the risk of heart attacks and death from cardiovascular disease, according to a study released today that critics say questions the government's ability to monitor drug safety. Patients who took Avandia to reduce their blood sugar levels were 43% more likely to have a heart attack than patients who were given other medications or a placebo.
June 15, 2007 | Carla Hall, Times Staff Writer
At 9:30 a.m. on Thursday, 12 boxes of alli, the first FDA-sanctioned diet drug to be sold without a prescription, were placed on the top shelf of a Santa Monica Walgreens' diet section. Four hours later, all but one had been sold. "I have never in my life experienced anything like this," store manager Roe Love, a pharmacist for 20 years, said as she eyed the empty space next to the last box of 90 capsules selling for $59.99.
January 4, 2003 | Greg Miller, Times Staff Writer
The Air Force calls them "go pills," and that is what they do: keep pilots going in the air long after their tired minds and bodies would have preferred to fall asleep. The stimulants have been used by fliers since World War II, and were doled out by the hundreds during the Persian Gulf War and in Afghanistan.
Los Angeles Times Articles